Patient Reported Outcomes/Metrics Program Trial - Palliative Radiation

What Is The PROMPT Study?

The PROMPT Study is a 1-year clinical trial that will monitor the Quality of Life (QoL) of 100 patients that are undergoing radiotherapy. Principal Investigators, Dr. Aisling Barry and Dr. Philip Wong from Princess Margaret Cancer Centre, are using Zamplo to monitor QoL and toxicity monitoring in a clinical trial known as PROMPT - Palliative Radiation.

Hexoskin is a wearable smart shirt that has been used to monitor astronauts' physiology around the clock as they orbit the planet. In the PROMPT study, cancer patients scheduled for radiation therapy will be wearing the Hexoskin shirt to record their health data and will use Zamplo to monitor their symptoms. Patients will be able to see a daily summary of their Hexoskin data in Zamplo.

ZR Website - Current Research Page Card Images

Goals of the Study

The study aims to assess the frequency of grade 2 or above radiotherapy-related adverse events with extended monitoring during and within 1 month of radiotherapy. By using Hexoskin, a wearable smart shirt that has been used to monitor astronauts' physiology, this study will evaluate:

Patient-Reported Outcomes

Electronic Survey Completion

Feasibility Outcomes

Zamplo's Role

In the PROMPT study, cancer patients scheduled for radiation therapy will be using Zamplo to monitor their symptoms and see a daily summary of their health data. Participants will:

Meet the Researchers

Research Studies Headshots (2)

Dr. Philip Wong

Principal Investigator

Dr. Philip Wong is a Radiation Oncologist at the Princess Margaret Cancer Centre interested in applying novel technologies in the care of cancer patients. This includes the evaluation of patient-facing applications and biometric tools for the monitoring of patients undergoing cancer treatments.

Research Studies Headshots (1)

Dr. Aisling Barry

Co-Principal Investigator

Dr. Aisling Barry is a radiation oncology staff member and assistant professor in the radiation medicine program at Princess Margaret Cancer Centre, Toronto, Canada and the University of Toronto since 2017.  She is currently the clinical lead of the Palliative Radiation Oncology Program and the Oligo-metastatic Program at Princess Margaret.

Revolutionize Clinical Research

Book a DemoBook a Meeting